Global Liquid Biopsy Market - 2025-2033
Global Liquid Biopsy Market reached US$ 9.07 billion in 2024 and is expected to reach US$ 25.19 billion by 2033, growing with a CAGR of 10.70% during the forecast period 2026-2033.
The Global Liquid Biopsy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Global Liquid Biopsy Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product Type
Both primary and secondary data sources have been used in the global Global Liquid Biopsy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Global Liquid Biopsy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Global Liquid Biopsy Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product Type
- Kits & Reagents*
- Instruments
- Services
- Circulating Tumor Cells*
- Circulating Tumor DNA (ctDNA)
- Cell-free DNA (cfDNA)
- Extracellular Vesicles
- Cancer Applications*
- Non-Cancer Applications
- Multi-gene-parallel Analysis (NGS)*
- Single Gene Analysis (PCR Microarrays)
- Hospitals and Physician Laboratories*
- Research Centers
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Global Liquid Biopsy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Circulating Biomarker
3.3. Snippet by Application
3.4. Snippet by Technology
3.5. Snippet by End User
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Cancer
4.1.1.2. Rise in Customized Laser Surgery Based on Eye Biomechanics
4.1.1.3. XX
4.1.2. Restraints
4.1.2.1. Standardization and Regulatory Challenges
4.1.2.2. High Cost of Treatment Procedures
4.1.2.3. XX
4.1.3. Opportunity
4.1.3.1. Expansion into Emerging Markets
4.1.3.2. XX
5. IMPACT ANALYSIS
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established leaders with largest selling Brand
6.1.3. Market leaders with established Product
6.2. CXO Perspectives
6.3. Latest Developments and Breakthroughs
6.4. Case Studies/Ongoing Research
6.5. Regulatory and Reimbursement Landscape
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East & Africa
6.6. Porter’s Five Force Analysis
6.7. Pipeline Analysis
6.8. Supply Chain Analysis
6.9. Patent Analysis
6.10. SWOT Analysis
6.11. Unmet Needs and Gaps
6.12. Recommended Strategies for Market Entry and Expansion
6.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.14. Pricing Analysis and Price Dynamics
6.15. Key Opinion Leaders
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Kits & Reagents*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Services
8. BY CIRCULATING BIOMARKER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
8.1.2. Market Attractiveness Index, By Circulating Biomarker
8.2. Circulating Tumor Cells*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Circulating Tumor DNA (ctDNA)
8.4. Cell-free DNA (cfDNA)
8.5. Extracellular Vesicles
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Cancer Applications*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Non-Cancer Applications
10. BY TECHNOLOGY
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.1.2. Market Attractiveness Index, By Technology
10.2. Multi-gene-parallel Analysis (NGS)*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Single Gene Analysis (PCR Microarrays)
11. BY END USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals and Physician Laboratories*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Research Centers
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Spain
12.3.8.5. Italy
12.3.8.6. Rest of Europe
12.4. Latin America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Mexico
12.4.8.2. Brazil
12.4.8.3. Argentina
12.4.8.4. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. South Korea
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
Key Market Players
1. EXOSOME SCIENCES INC*
1.1. Company Overview
1.1.1. Product Portfolio
1.1.1.1. Product Description
1.1.1.2. Product Key Performance Indicators (KPIs)
1.1.1.3. Historic and Forecasted Product Sales
1.1.1.4. Product Sales Volume
1.1.2. Financial Overview
1.1.2.1. Company Revenue’s
1.1.2.2. Geographical Revenue Shares
1.1.2.3. Revenue Forecasts
1.1.3. Key Developments
1.1.3.1. Mergers & Acquisitions
1.1.3.2. Key Product Development Activities
1.1.3.3. Regulatory Approvals etc.
1.1.4. SWOT Analysis
1.2. Illumina, Inc
1.3. Guardant Health
1.4. Thermo Fisher Scientific Inc
1.5. NeoGenomics Laboratories
1.6. Qiagen
1.7. BioChain Institute Inc
1.8. Sysmex Europe SE
1.9. Eurofins Genomics
1.10. Goffin Molecular Technologies
* Similar data will be provided for each market player.
Emerging Market Players
1. EXACT SCIENCES*
1.1. Pipeline Products Description
1.1.1. Product Key Performance Indicators (KPIs)
1.1.2. Key Activities
1.1.3. Market Entry Timelines
1.1.4. Product Penetration Rate
1.1.5. Sales Estimation and Projections
1.2. Tempus
1.3. Dxcover Limited
* Similar data will be provided for each market player.
LIST NOT EXHAUSTIVE
1. APPENDIX
1.1. About Us and Services
1.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Circulating Biomarker
3.3. Snippet by Application
3.4. Snippet by Technology
3.5. Snippet by End User
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Cancer
4.1.1.2. Rise in Customized Laser Surgery Based on Eye Biomechanics
4.1.1.3. XX
4.1.2. Restraints
4.1.2.1. Standardization and Regulatory Challenges
4.1.2.2. High Cost of Treatment Procedures
4.1.2.3. XX
4.1.3. Opportunity
4.1.3.1. Expansion into Emerging Markets
4.1.3.2. XX
5. IMPACT ANALYSIS
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established leaders with largest selling Brand
6.1.3. Market leaders with established Product
6.2. CXO Perspectives
6.3. Latest Developments and Breakthroughs
6.4. Case Studies/Ongoing Research
6.5. Regulatory and Reimbursement Landscape
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East & Africa
6.6. Porter’s Five Force Analysis
6.7. Pipeline Analysis
6.8. Supply Chain Analysis
6.9. Patent Analysis
6.10. SWOT Analysis
6.11. Unmet Needs and Gaps
6.12. Recommended Strategies for Market Entry and Expansion
6.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.14. Pricing Analysis and Price Dynamics
6.15. Key Opinion Leaders
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Kits & Reagents*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Services
8. BY CIRCULATING BIOMARKER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
8.1.2. Market Attractiveness Index, By Circulating Biomarker
8.2. Circulating Tumor Cells*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Circulating Tumor DNA (ctDNA)
8.4. Cell-free DNA (cfDNA)
8.5. Extracellular Vesicles
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Cancer Applications*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Non-Cancer Applications
10. BY TECHNOLOGY
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.1.2. Market Attractiveness Index, By Technology
10.2. Multi-gene-parallel Analysis (NGS)*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Single Gene Analysis (PCR Microarrays)
11. BY END USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals and Physician Laboratories*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Research Centers
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Spain
12.3.8.5. Italy
12.3.8.6. Rest of Europe
12.4. Latin America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Mexico
12.4.8.2. Brazil
12.4.8.3. Argentina
12.4.8.4. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. South Korea
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
Key Market Players
1. EXOSOME SCIENCES INC*
1.1. Company Overview
1.1.1. Product Portfolio
1.1.1.1. Product Description
1.1.1.2. Product Key Performance Indicators (KPIs)
1.1.1.3. Historic and Forecasted Product Sales
1.1.1.4. Product Sales Volume
1.1.2. Financial Overview
1.1.2.1. Company Revenue’s
1.1.2.2. Geographical Revenue Shares
1.1.2.3. Revenue Forecasts
1.1.3. Key Developments
1.1.3.1. Mergers & Acquisitions
1.1.3.2. Key Product Development Activities
1.1.3.3. Regulatory Approvals etc.
1.1.4. SWOT Analysis
1.2. Illumina, Inc
1.3. Guardant Health
1.4. Thermo Fisher Scientific Inc
1.5. NeoGenomics Laboratories
1.6. Qiagen
1.7. BioChain Institute Inc
1.8. Sysmex Europe SE
1.9. Eurofins Genomics
1.10. Goffin Molecular Technologies
* Similar data will be provided for each market player.
Emerging Market Players
1. EXACT SCIENCES*
1.1. Pipeline Products Description
1.1.1. Product Key Performance Indicators (KPIs)
1.1.2. Key Activities
1.1.3. Market Entry Timelines
1.1.4. Product Penetration Rate
1.1.5. Sales Estimation and Projections
1.2. Tempus
1.3. Dxcover Limited
* Similar data will be provided for each market player.
LIST NOT EXHAUSTIVE
1. APPENDIX
1.1. About Us and Services
1.2. Contact Us
